Royal Bank of Canada’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.9M Sell
729,683
-32,722
-4% -$1.92M 0.01% 1045
2025
Q4
$47.4M Buy
762,405
+17,355
+2% +$1.07M 0.01% 973
2025
Q3
$44.8M Buy
745,050
+71,975
+11% +$4.4M 0.01% 1072
2025
Q2
$42.2M Sell
673,075
-25,887
-4% -$1.56M 0.01% 1036
2025
Q1
$42.1M Sell
698,962
-11,709
-2% -$727K 0.01% 877
2024
Q4
$41.5M Sell
710,671
-60,090
-8% -$3.57M 0.01% 920
2024
Q3
$45.6M Sell
770,761
-33,190
-4% -$1.9M 0.01% 854
2024
Q2
$45.1M Sell
803,951
-32,968
-4% -$1.85M 0.01% 817
2024
Q1
$49M Sell
836,919
-232,080
-22% -$13.1M 0.01% 785
2023
Q4
$57.7M Buy
1,068,999
+259,155
+32% +$12.7M 0.01% 728
2023
Q3
$39.3M Buy
809,844
+8,647
+1% +$460K 0.01% 798
2023
Q2
$45.2M Sell
801,197
-62,558
-7% -$3.45M 0.01% 746
2023
Q1
$46.6M Sell
863,755
-167,314
-16% -$8.91M 0.01% 706
2022
Q4
$54.2M Buy
1,031,069
+47,157
+5% +$2.39M 0.02% 656
2022
Q3
$46.4M Sell
983,912
-5,838
-0.6% -$303K 0.01% 669
2022
Q2
$49.9M Sell
989,750
-221,125
-18% -$12.1M 0.01% 655
2022
Q1
$73.8M Buy
1,210,875
+7,739
+0.6% +$461K 0.02% 605
2021
Q4
$79.2M Buy
1,203,136
+33,789
+3% +$2.16M 0.02% 612
2021
Q3
$73.4M Sell
1,169,347
-1,529
-0.1% -$97.6K 0.02% 601
2021
Q2
$70.5M Sell
1,170,876
-52,722
-4% -$3.05M 0.02% 600
2021
Q1
$67.4M Sell
1,223,598
-169,410
-12% -$9.39M 0.02% 581
2020
Q4
$76M Sell
1,393,008
-250,470
-15% -$13.1M 0.02% 542
2020
Q3
$82.1M Buy
1,643,478
+214,992
+15% +$10.4M 0.03% 448
2020
Q2
$63M Buy
1,428,486
+490,188
+52% +$20.9M 0.03% 493
2020
Q1
$35.2M Sell
938,298
-175,932
-16% -$7.41M 0.02% 634
2019
Q4
$49.1M Buy
1,114,230
+55,368
+5% +$2.33M 0.02% 637
2019
Q3
$43.6M Sell
1,058,862
-894
-0.1% -$36.6K 0.02% 649
2019
Q2
$42.5M Buy
1,059,756
+41,586
+4% +$1.57M 0.02% 652
2019
Q1
$39.3M Buy
1,018,170
+180,000
+21% +$6.53M 0.02% 670
2018
Q4
$27.9M Buy
838,170
+118,008
+16% +$4.09M 0.01% 802
2018
Q3
$27.3M Buy
720,162
+43,236
+6% +$1.54M 0.01% 931
2018
Q2
$22.6M Buy
676,926
+63,018
+10% +$2.05M 0.01% 1003
2018
Q1
$18.9M Buy
613,908
+80,124
+15% +$2.47M 0.01% 1125
2017
Q4
$15.4M Sell
533,784
-31,596
-6% -$911K 0.01% 1303
2017
Q3
$15.7M Sell
565,380
-15,660
-3% -$433K 0.01% 1239
2017
Q2
$16.1M Buy
581,040
+103,830
+22% +$2.75M 0.01% 1199
2017
Q1
$12M Buy
477,210
+96,522
+25% +$2.34M 0.01% 1381
2016
Q4
$8.45M Sell
380,688
-57,540
-13% -$1.31M ﹤0.01% 1621
2016
Q3
$10.6M Buy
438,228
+110,496
+34% +$2.63M 0.01% 1437
2016
Q2
$7.4M Buy
327,732
+50,958
+18% +$1.1M ﹤0.01% 1648
2016
Q1
$5.65M Buy
276,774
+192,078
+227% +$3.73M ﹤0.01% 1743
2015
Q4
$1.73M Sell
84,696
-6,906
-8% -$138K ﹤0.01% 2663
2015
Q3
$1.7M Sell
91,602
-5,970
-6% -$120K ﹤0.01% 2409
2015
Q2
$1.95M Buy
97,572
+2,358
+2% +$47.2K ﹤0.01% 2339
2015
Q1
$1.91M Buy
95,214
+32,580
+52% +$636K ﹤0.01% 2318
2014
Q4
$1.18M Sell
62,634
-69,084
-52% -$1.25M ﹤0.01% 2786
2014
Q3
$2.18M Buy
131,718
+2,838
+2% +$48.3K ﹤0.01% 2235
2014
Q2
$2.19M Sell
128,880
-130,206
-50% -$2.13M ﹤0.01% 2242
2014
Q1
$4.27M Buy
259,086
+104,364
+67% +$1.67M ﹤0.01% 1684
2013
Q4
$2.39M Buy
154,722
+78,072
+102% +$1.16M ﹤0.01% 2163
2013
Q3
$1.08M Sell
76,650
-3,576
-4% -$49.1K ﹤0.01% 2698
2013
Q2
$1.05M Buy
+80,226
New +$1.04M ﹤0.01% 2530

Other funds holding IHI

Royal Bank of Canada's IHI Position: Q1 2026 in Review

Royal Bank of Canada reduced its iShares US Medical Devices ETF (IHI) stake by 4.3% in Q1 2026, selling an estimated $1.92M and leaving 729,683 shares worth $38.9M. The position accounts for 0.01% of the portfolio, ranked #1045.

Royal Bank of Canada first reported a position in IHI in Q2 2013 and has held it in 52 quarters since. The position peaked at $82.1M in Q3 2020. 505 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Royal Bank of Canada held 729,683 shares of iShares US Medical Devices ETF worth $38.9M as of Q1 2026.
  • Royal Bank of Canada sold 32,722 iShares US Medical Devices ETF shares in Q1 2026, an estimated $1.92M.
  • iShares US Medical Devices ETF made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1045 holding.
  • Royal Bank of Canada first reported a position in iShares US Medical Devices ETF in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's iShares US Medical Devices ETF position peaked at $82.1M in Q3 2020.
  • 505 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.